AU2011279402A1 - Improved methods for the sterilization of bendamustine - Google Patents

Improved methods for the sterilization of bendamustine Download PDF

Info

Publication number
AU2011279402A1
AU2011279402A1 AU2011279402A AU2011279402A AU2011279402A1 AU 2011279402 A1 AU2011279402 A1 AU 2011279402A1 AU 2011279402 A AU2011279402 A AU 2011279402A AU 2011279402 A AU2011279402 A AU 2011279402A AU 2011279402 A1 AU2011279402 A1 AU 2011279402A1
Authority
AU
Australia
Prior art keywords
bendamustine
solid
sterilization
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2011279402A
Other languages
English (en)
Inventor
Rachel Y. Labell
Piyush R. Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cephalon LLC
Original Assignee
Cephalon LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon LLC filed Critical Cephalon LLC
Publication of AU2011279402A1 publication Critical patent/AU2011279402A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/081—Gamma radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/08—Radiation
    • A61L2/087—Particle radiation, e.g. electron-beam, alpha or beta radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Apparatus For Disinfection Or Sterilisation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU2011279402A 2010-07-13 2011-07-12 Improved methods for the sterilization of bendamustine Abandoned AU2011279402A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36384710P 2010-07-13 2010-07-13
US61/363,847 2010-07-13
PCT/US2011/043614 WO2012009299A1 (en) 2010-07-13 2011-07-12 Improved methods for the sterilization of bendamustine

Publications (1)

Publication Number Publication Date
AU2011279402A1 true AU2011279402A1 (en) 2013-01-31

Family

ID=44510172

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2011279402A Abandoned AU2011279402A1 (en) 2010-07-13 2011-07-12 Improved methods for the sterilization of bendamustine

Country Status (8)

Country Link
US (1) US20130144068A1 (https=)
EP (1) EP2593144A1 (https=)
JP (1) JP2013534537A (https=)
CN (1) CN103052407A (https=)
AU (1) AU2011279402A1 (https=)
CA (1) CA2804865A1 (https=)
MX (1) MX2013000373A (https=)
WO (1) WO2012009299A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107375965B (zh) * 2017-07-18 2019-02-15 江门华大生物科技有限公司 中药饮片无硫杀虫保藏方法
KR102086318B1 (ko) * 2018-03-12 2020-03-09 주식회사 코스메카코리아 감마선 조사를 통한 유연성을 가지는 고형의 경시적 색변화 하이드로겔 화장료 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422068A (en) * 1994-01-05 1995-06-06 Shalaby; Shalaby W. Radiochemical sterilization
CN2225245Y (zh) * 1995-06-20 1996-04-24 鞍山钢铁公司 快速微型固体干热消毒装置
US6632648B1 (en) * 1996-05-14 2003-10-14 Elan Drug Delivery Limited Methods of terminal sterilization of fibrinogen
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
CN101366954B (zh) * 2008-09-19 2013-03-20 乐普（北京）医疗器械股份有限公司 一种生物涂层医疗装置的灭菌处理方法
EP2346836B1 (en) * 2008-10-08 2018-03-07 Cephalon, Inc. Processes for the preparation of bendamustine

Also Published As

Publication number Publication date
WO2012009299A1 (en) 2012-01-19
CN103052407A (zh) 2013-04-17
JP2013534537A (ja) 2013-09-05
CA2804865A1 (en) 2012-01-19
MX2013000373A (es) 2013-02-15
US20130144068A1 (en) 2013-06-06
EP2593144A1 (en) 2013-05-22

Similar Documents

Publication Publication Date Title
JP4785816B2 (ja) 抗新生物薬剤、特にテモゾロミドの薬学的処方物、その同一物の製造方法および使用方法
US20140142153A1 (en) Bendamustine formulations
JP2015110639A (ja) デキスメデトミジンプレミックス製剤
WO2013117969A1 (en) Process for preparing stable pharmaceutical compositions of compounds susceptible to hydrolysis
EP2958554B1 (en) Stable compositions of bendamustine
KR102459213B1 (ko) 카르글룸산을 함유하는 약제학적 비경구 제형
JP2016521731A (ja) 抗がん剤を含む安定な水溶性医薬組成物
CN1646175A (zh) 获得2－18f－氟－2－脱氧－d－葡萄糖(18f－fdg)溶液的方法
JP6248189B2 (ja) 安定な抗がん剤のアルギニン塩とそれを含む組成物
KR20240156387A (ko) 엔시펜트린을 포함하는 멸균 액상 약제학적 조성물의 멸균 방법
US20130144068A1 (en) Methods for the Sterilization of Bendamustine
KR20150132835A (ko) 변형된 가요성 플라스틱 용기에서 즉시 사용가능한 공용매 약학 조성물
WO2015092758A1 (en) Liquid pharmaceutical formulations of pemetrexed
AU2017215419B2 (en) Process of manufacturing a stable, ready to use infusion bag for an oxidation sensitive formulation
TW202404607A (zh) 醫藥製劑之滅菌法與包裝體
JP2012232958A (ja) 注射製剤
JP2001519395A (ja) カルバマゼピンまたはその誘導体を含む非経口製剤
CA2867224A1 (en) Process for preparing sterile brinzolamide
JP2007533724A (ja) 無秩序なセフォベシンナトリウム塩を安定させる方法
CN100352438C (zh) 米力农冻干粉针剂及其制备方法
EP1938798A1 (en) Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same
CN121793947A (zh) 药物组合物
Varshney et al. Studies of radiation effects on allopathic formulations for cancer management
WO2010017999A1 (en) Process
HK1115327A (en) Pharmaceutical formulations of antineoplastic agents, in particular temozolomide, processes of making and using the same

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application